These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 31144522)
1. Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Ngo ST; van Eijk RPA; Chachay V; van den Berg LH; McCombe PA; Henderson RD; Steyn FJ Amyotroph Lateral Scler Frontotemporal Degener; 2019 Nov; 20(7-8):497-505. PubMed ID: 31144522 [No Abstract] [Full Text] [Related]
2. Lower hypothalamic volume with lower body mass index is associated with shorter survival in patients with amyotrophic lateral sclerosis. Chang J; Shaw TB; Holdom CJ; McCombe PA; Henderson RD; Fripp J; Barth M; Guo CC; Ngo ST; Steyn FJ; Eur J Neurol; 2023 Jan; 30(1):57-68. PubMed ID: 36214080 [TBL] [Abstract][Full Text] [Related]
3. Associations of postprandial ghrelin, liver-expressed antimicrobial peptide 2 and leptin levels with body composition, disease progression and survival in patients with amyotrophic lateral sclerosis. Howe SL; Holdom CJ; McCombe PA; Henderson RD; Zigman JM; Ngo ST; Steyn FJ Eur J Neurol; 2024 Jan; 31(1):e16052. PubMed ID: 37658515 [TBL] [Abstract][Full Text] [Related]
4. Loss of appetite in patients with amyotrophic lateral sclerosis is associated with weight loss and anxiety/depression. Wang Y; Ye S; Chen L; Tang L; Fan D Sci Rep; 2021 Apr; 11(1):9119. PubMed ID: 33907295 [TBL] [Abstract][Full Text] [Related]
5. Fat mass loss correlates with faster disease progression in amyotrophic lateral sclerosis patients: Exploring the utility of dual-energy x-ray absorptiometry in a prospective study. Lee I; Kazamel M; McPherson T; McAdam J; Bamman M; Amara A; Smith DL; King PH PLoS One; 2021; 16(5):e0251087. PubMed ID: 33956876 [TBL] [Abstract][Full Text] [Related]
6. Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia. Peter RS; Rosenbohm A; Dupuis L; Brehme T; Kassubek J; Rothenbacher D; Nagel G; Ludolph AC Eur J Epidemiol; 2017 Oct; 32(10):901-908. PubMed ID: 28975435 [TBL] [Abstract][Full Text] [Related]
7. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey. Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193 [TBL] [Abstract][Full Text] [Related]
8. Loss of appetite in amyotrophic lateral sclerosis is associated with weight loss and decreased calorie consumption independent of dysphagia. Mezoian T; Belt E; Garry J; Hubbard J; Breen CT; Miller L; Levine-Weinberg M; Nalipinski P; Sullivan S; Chan J; Wills AM Muscle Nerve; 2020 Feb; 61(2):230-234. PubMed ID: 31650547 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of body weight variation after diagnosis in ALS: a single-centre prospective cohort study. Shimizu T; Nakayama Y; Matsuda C; Haraguchi M; Bokuda K; Ishikawa-Takata K; Kawata A; Isozaki E J Neurol; 2019 Jun; 266(6):1412-1420. PubMed ID: 30868220 [TBL] [Abstract][Full Text] [Related]
10. Hypermetabolism in ALS is associated with greater functional decline and shorter survival. Steyn FJ; Ioannides ZA; van Eijk RPA; Heggie S; Thorpe KA; Ceslis A; Heshmat S; Henders AK; Wray NR; van den Berg LH; Henderson RD; McCombe PA; Ngo ST J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1016-1023. PubMed ID: 29706605 [TBL] [Abstract][Full Text] [Related]
11. Early weight instability is associated with cognitive decline and poor survival in amyotrophic lateral sclerosis. Wei QQ; Ou R; Cao B; Chen Y; Hou Y; Zhang L; Wu F; Shang H Brain Res Bull; 2021 Jun; 171():10-15. PubMed ID: 33636227 [TBL] [Abstract][Full Text] [Related]
12. Fat-rich versus carbohydrate-rich nutrition in ALS: a randomised controlled study. Dorst J; Doenz J; Kandler K; Dreyhaupt J; Tumani H; Witzel S; Schuster J; Ludolph AC J Neurol Neurosurg Psychiatry; 2022 Mar; 93(3):298-302. PubMed ID: 35022317 [TBL] [Abstract][Full Text] [Related]
13. Correlation of weight and body composition with disease progression rate in patients with amyotrophic lateral sclerosis. Li JY; Sun XH; Cai ZY; Shen DC; Yang XZ; Liu MS; Cui LY Sci Rep; 2022 Aug; 12(1):13292. PubMed ID: 35918363 [TBL] [Abstract][Full Text] [Related]
14. High-caloric food supplements in the treatment of amyotrophic lateral sclerosis: a prospective interventional study. Dorst J; Cypionka J; Ludolph AC Amyotroph Lateral Scler Frontotemporal Degener; 2013 Dec; 14(7-8):533-6. PubMed ID: 23944684 [TBL] [Abstract][Full Text] [Related]
15. Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. Marin B; Desport JC; Kajeu P; Jesus P; Nicolaud B; Nicol M; Preux PM; Couratier P J Neurol Neurosurg Psychiatry; 2011 Jun; 82(6):628-34. PubMed ID: 21097551 [TBL] [Abstract][Full Text] [Related]
16. Nutritional assessment of amyotrophic lateral sclerosis in routine practice: value of weighing and bioelectrical impedance analysis. Roubeau V; Blasco H; Maillot F; Corcia P; Praline J Muscle Nerve; 2015 Apr; 51(4):479-84. PubMed ID: 25130859 [TBL] [Abstract][Full Text] [Related]
18. Weight loss, dysphagia and supplement intake in patients with amyotrophic lateral sclerosis (ALS): impact on quality of life and therapeutic options. Körner S; Hendricks M; Kollewe K; Zapf A; Dengler R; Silani V; Petri S BMC Neurol; 2013 Jul; 13():84. PubMed ID: 23848967 [TBL] [Abstract][Full Text] [Related]
19. Body weight variation predicts disease progression after invasive ventilation in amyotrophic lateral sclerosis. Nakayama Y; Shimizu T; Matsuda C; Haraguchi M; Hayashi K; Bokuda K; Nagao M; Kawata A; Ishikawa-Takata K; Isozaki E Sci Rep; 2019 Aug; 9(1):12262. PubMed ID: 31439899 [TBL] [Abstract][Full Text] [Related]
20. Hypermetabolism associated with worse prognosis of amyotrophic lateral sclerosis. He J; Fu J; Zhao W; Ren C; Liu P; Chen L; Li D; Tang L; Zhou L; Zhang Y; Ma X; Zhang G; Li N; Fan D J Neurol; 2022 Mar; 269(3):1447-1455. PubMed ID: 34274994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]